Effect of pioglitazone on metabolic syndrome risk factors: results of double-blind, multicenter, randomized clinical trials

Author: Rajagopalan Rukmini   Iyer Shrividya   Khan Mehmood  

Publisher: Informa Healthcare

E-ISSN: 0300-7995|21|1|163-172

ISSN: 1473-4877

Source: Current Medical Research and Opinion, Vol.21, Iss.1, 2005-01, pp. : 163-172

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content